Press Releases | PTC Therapeutics, Inc.

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Year

May 21, 2014

PTC Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

PTC Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference SOUTH PLAINFIELD, NJ May 21, 2014 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will present a company overview at the Jefferies 2014 Global Healthcare Conference on Wednesday, June 4th at

May 16, 2014

Ataluren Phase 3 Trial Results in Nonsense Mutation Cystic Fibrosis Published in The Lancet Respiratory Medicine

Data Demonstrate Positive Trends in Lung Function and Pulmonary Exacerbations

May 06, 2014

PTC Therapeutics Reports First Quarter Financial Results and Provides Corporate Update

-Conference Call Today at 4:30 pm ET-

Apr 23, 2014

PTC THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

SOUTH PLAINFIELD, NJ – April 23, 2014 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will present a company overview at two upcoming investor conferences: - Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7th at 10:00 am ET in Boston - UBS Global Healthcare

Apr 22, 2014

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results SOUTH PLAINFIELD, NJ April 22, 2014 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2014 financial results on

Apr 21, 2014

PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635©(4)

PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) SOUTH PLAINFIELD, N.J., APRIL 21, 2014 -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 17, 2014 it granted non-statutory stock options to purchase an aggregate of 9,800 shares of its common

Mar 06, 2014

PTC Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update

-Conference Call Today at 4:30 pm ET-

Feb 28, 2014

PTC THERAPEUTICS TO PRESENT AT THE COWEN & COMPANY 34TH ANNUAL HEALTH CARE CONFERENCE

SOUTH PLAINFIELD, NJ – February 28, 2014 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will present a company overview at the Cowen & Company 34th Annual Health Care Conference on Wednesday, March 5th at 9:20 am ET at the Marriott Copley Plaza Hotel in Boston.

Feb 27, 2014

PTC THERAPEUTICS TO HOST FOURTH QUARTER AND YEAR END 2013 FINANCIAL RESULTS CONFERENCE CALL

SOUTH PLAINFIELD, NJ – February 27, 2014 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that will host a webcast conference call to discuss financial results for the fourth quarter and year end 2013 on Thursday, March 6, 2014 at 4:30 p.m. (ET) after the closing of the market.

Feb 27, 2014

PTC THERAPEUTICS REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635 (c )(4)

SOUTH PLAINFIELD, NJ – February 27, 2014 – PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it granted a non-statutory stock option to purchase 150,000 shares of its common stock to Robert Spiegel, M.D., PTC's newly appointed Chief Medical Officer.

Pagination

First page
Previous page
…
Page 49
Page 50
Current page 51
Page 52
Page 53
…
Next page
Last page